Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,644 | 74 | 97.1% |
| Entertainment | $110.54 | 1 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $536.55 | 2 | $0 (2022) |
| Genentech USA, Inc. | $430.17 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $376.97 | 13 | $0 (2024) |
| Astellas Pharma US Inc | $355.63 | 7 | $0 (2024) |
| ABBVIE INC. | $308.94 | 13 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $299.88 | 4 | $0 (2024) |
| Allergan, Inc. | $275.05 | 3 | $0 (2021) |
| RxSight Inc | $262.35 | 3 | $0 (2024) |
| Genentech, Inc. | $221.81 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $191.81 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $756.60 | 21 | Regeneron Healthcare Solutions, Inc. ($170.36) |
| 2023 | $1,016 | 22 | Apellis Pharmaceuticals, Inc. ($265.84) |
| 2022 | $809.63 | 16 | Genentech, Inc. ($190.31) |
| 2021 | $177.71 | 3 | Genentech USA, Inc. ($132.63) |
| 2020 | $24.42 | 1 | Bausch & Lomb, a division of Bausch Health US, LLC ($24.42) |
| 2019 | $643.44 | 4 | Alcon Vision LLC ($434.47) |
| 2018 | $56.96 | 3 | Regeneron Healthcare Solutions, Inc. ($41.99) |
| 2017 | $269.81 | 5 | Allergan Inc. ($143.36) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $111.21 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/31/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/15/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: Ophthalmology | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $39.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Ophthalmology | ||||||
| 09/17/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/28/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: Ophthalmology | ||||||
| 08/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/06/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 07/10/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Ophthalmology | ||||||
| 04/18/2024 | Astellas Pharma Global Development | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Ophthalmology | ||||||
| 04/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/03/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: EYE CARE | ||||||
| 02/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $38.37 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: EYE CARE | ||||||
| 02/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Immunology and Ophthalmology | ||||||
| 02/15/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 01/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $29.10 | General |
| 11/07/2023 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $87.91 | General |
| Category: Ophthalmology | ||||||
| 10/26/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: EYE CARE | ||||||
| 10/11/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: EYE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,555 | 15,518 | $6.1M | $1.3M |
| 2022 | 15 | 2,262 | 7,302 | $4.4M | $1.2M |
| 2021 | 12 | 457 | 929 | $427,943 | $161,648 |
| 2020 | 4 | 72 | 72 | $29,737 | $9,561 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 102 | 966 | $2.4M | $663,823 | 27.5% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 23 | 8,340 | $1.0M | $242,155 | 23.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 497 | 1,283 | $469,578 | $117,745 | 25.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 29 | 574 | $574,000 | $107,249 | 18.7% |
| 67028 | Injection of drug into eye | Office | 2023 | 140 | 708 | $412,868 | $64,941 | 15.7% |
| 92134 | Imaging of retina | Office | 2023 | 597 | 1,684 | $757,800 | $51,456 | 6.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 132 | 132 | $62,040 | $16,390 | 26.4% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 13 | 14 | $52,948 | $13,108 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 151 | $54,662 | $13,092 | 24.0% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 411 | 955 | $109,825 | $11,350 | 10.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 84 | 84 | $36,204 | $8,031 | 22.2% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 266 | 396 | $49,500 | $7,385 | 14.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 64 | 66 | $24,618 | $6,631 | 26.9% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 18 | 22 | $26,928 | $3,657 | 13.6% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 64 | 98 | $25,774 | $3,602 | 14.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 14 | 29 | $19,024 | $1,657 | 8.7% |
| 92250 | Photography of the retina | Office | 2023 | 15 | 16 | $3,104 | $475.77 | 15.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 80 | 884 | $1.8M | $633,136 | 35.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 55 | 1,308 | $1.0M | $290,188 | 28.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 387 | 727 | $219,450 | $68,701 | 31.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 131 | 651 | $391,714 | $61,432 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 505 | $133,530 | $48,823 | 36.6% |
| 92134 | Imaging of retina | Office | 2022 | 522 | 1,530 | $464,375 | $48,064 | 10.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 159 | 159 | $55,129 | $16,408 | 29.8% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2022 | 14 | 14 | $61,108 | $15,162 | 24.8% |
About Dr. Osama Sabbagh, MD
Dr. Osama Sabbagh, MD is a Ophthalmology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2015. The National Provider Identifier (NPI) number assigned to this provider is 1548647928.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Osama Sabbagh, MD has received a total of $3,755 in payments from pharmaceutical and medical device companies, with $756.60 received in 2024. These payments were reported across 75 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,644).
As a Medicare-enrolled provider, Sabbagh has provided services to 5,346 Medicare beneficiaries, totaling 23,821 services with total Medicare billing of $2.7M. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist, Ophthalmology
- Location Lexington, KY
- Active Since 05/05/2015
- Last Updated 07/08/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1548647928
Products in Payments
- OZURDEX (Drug) $583.99
- Syfovre (Drug) $299.88
- SUSVIMO (Drug) $206.42
- Vabysmo (Drug) $196.31
- Izervay (Drug) $179.69
- EYLEA HD (Biological) $169.43
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) $151.14
- OXERVATE (Drug) $124.74
- EYLEA (Biological) $113.85
- RXSIGHT CONTACT LENS (Device) $111.21
- Clareon (Device) $102.08
- VABYSMO (Drug) $97.99
- EYLEA AFLIBERCEPT INJECTION (Biological) $93.69
- EVA, combined machine (Device) $87.91
- DUREZOL (Drug) $59.17
- Cimerli (Biological) $45.54
- YUTIQ (Drug) $43.73
- ILUVIEN (Drug) $34.28
- TRAVATAN Z (Drug) $32.79
- VISUDYNE (Drug) $24.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Lexington
Dr. John Kitchens, M.d, M.D
Ophthalmology — Payments: $1.2M
Dr. Jeremy Kieval, M.d, M.D
Ophthalmology — Payments: $354,855
Gary Wortz, Md, MD
Ophthalmology — Payments: $195,872
Blake Isernhagen, Md, MD
Ophthalmology — Payments: $188,723
Dr. Bruce Koffler, Md, MD
Ophthalmology — Payments: $100,236
Kunal Kanitkar, M.d, M.D
Ophthalmology — Payments: $75,249